Related references
Note: Only part of the references are listed.Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Jie Deng et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer
Asmaa El-Kenawi et al.
BRITISH JOURNAL OF CANCER (2019)
Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation
Nishant Mehta et al.
CELL REPORTS (2019)
VISTA is an acidic pH-selective ligand for PSGL-1
Robert J. Johnston et al.
NATURE (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
Blocking the VISTA pathway enhances disease progression in (NZBxNZW) F1 female mice
P. A. Sergent et al.
LUPUS (2018)
Hypoxia and acidosis: immune suppressors and therapeutic targets
Sultan Damgaci et al.
IMMUNOLOGY (2018)
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Shari Pilon-Thomas et al.
CANCER RESEARCH (2016)
PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion
Roberto Tinoco et al.
IMMUNITY (2016)
VISTA Regulates the Development of Protective Antitumor Immunity
Isabelle Le Mercier et al.
CANCER RESEARCH (2014)
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Li Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules
O Rötzschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
